Advanced HCC with amplified mesenchymal epithelial transition factor receptor responds well to savolitinib: a case report (vol 10, 1130012, 2023)
FRONTIERS IN MEDICINE（2023）
Key words
liver cancer,tyrosine kinase inhibitors,MET,savolitinib,MET-TKI
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined